Steve Rodgers
Managing Director
Steve Rodgers
Managing Director

Steve Rodgers

Managing Director

 
 
Background
Steven Rodgers is a Managing Director of Morgan Stanley Capital Partners (MSCP). He is based in New York and has 21 years of investing experience. 

Mr. Rodgers joined Morgan Stanley in 2018 from J.H. Whitney Capital Partners, where he was a Senior Managing Director focusing on private equity investments. At Whitney Mr. Rodgers was a member of the Investment Committee and led the firm’s healthcare investing activities. Mr. Rodgers was a Managing Partner at the Riverside Company, a global private equity firm, where he led the firm’s efforts to invest in public companies utilizing a private equity approach. He was also a financial analyst at Alex. Brown & Sons Incorporated. Mr. Rodgers serves on the board of directors of Aveanna Healthcare, 3B Scientific and previously served on the board of directors of a number of other healthcare companies, including Amisys Synertech, Herbalife, Patient Keeper, and Symbion. 

Mr. Rodgers graduated, cum laude, from Dartmouth College, and holds an MBA from The Stanford University Graduate School of Business.
 
 
News & Insights
Press Release
Fisher Rebrands to PPC Flexible Packaging
Feb 26, 2018
Fisher Container Holdings, LLC announced the rebranding of its subsidiaries Fisher Container, LLC and Packaging Products Corporation, LLC into the new entity PPC Flexible Packaging.
Press Release
Fisher Container Adds Industry Vet Dan Donofrio
Feb 05, 2018
Fisher Container, a portfolio company majority owned by investment funds managed by Morgan Stanley Capital Partners, announced the addition of Dan Donofrio to its executive team.
Press Release
MSCP Completes the Sale of Zenith
Mar 06, 2014
MSCP announces the completion of the sale of its majority interest in Accelerate Acquisitions Limited, the parent company of Zenith, to HgCapital, a UK-based private equity fund.
 

Team members may change from time to time.

The information on this page is for informational purposes only. It is intended for the benefit of third party issuers and those seeking information about alternatives investment strategies. The information contained herein does not constitute and should not be construed as an offering of advisory services or an offer to sell or a solicitation of an offer to buy any securities in any jurisdiction in which such offer or solicitation, purchase or sale would be unlawful under the securities, insurance or other laws of such jurisdiction.

All investing involves risks, including a loss of principal. Alternative investments are speculative and involve a high degree of risk. These investments are designed for investors who understand and are willing to accept these risks. Performance may be volatile, and an investor could lose all or a substantial portion of his or her investment.

Please refer to the strategy detail page for important information on the strategy, including additional risk considerations.

 

It is important that users read the Terms of Use before proceeding as it explains certain legal and regulatory restrictions applicable to the dissemination of information pertaining to Morgan Stanley Investment Management's investment products.

The services described on this website may not be available in all jurisdictions or to all persons. For further details, please see our Terms of Use.


Privacy & Cookies    •    Terms of Use

©  Morgan Stanley. All rights reserved.